News & Updates
Filter by Specialty:
Week 2 adalimumab levels predict clinical remission in IBD patients
Serum levels of adalimumab at week 2 is associated with short-term clinical remission in patients with inflammatory bowel disease (IBD), a study has shown.
Week 2 adalimumab levels predict clinical remission in IBD patients
23 Sep 2022
Low zinc, vitamin D levels may predict susceptibility to COVID-19
Patients with COVID-19 show very low levels of 25-hydroxyvitamin D and zinc, regardless of age, sex, and comorbidities, reports a study. Vitamin D and zinc deficiency appears to be relevant factors in identifying individuals who are susceptible to SARS-CoV-2 infection.
Low zinc, vitamin D levels may predict susceptibility to COVID-19
23 Sep 2022
Counseling tied to lower 30-day hospital readmission in acute alcoholic pancreatitis
A recent study has found that less than half of patients with alcohol-induced acute pancreatitis (AAP) receive alcohol counseling.
Counseling tied to lower 30-day hospital readmission in acute alcoholic pancreatitis
23 Sep 2022
Rocatinlimab a new treatment option for head and neck AD?
Rocatinlimab improved disease severity in patients with moderate-to-severe head and neck atopic dermatitis (H&N AD), a post hoc analysis of a phase IIb trial has shown.
Rocatinlimab a new treatment option for head and neck AD?
23 Sep 2022
Play-based exercise boosts fitness, fundamental movement in kids with bronchiectasis
Children suffering from bronchiectasis may benefit from a play-based therapeutic exercise regimen, which results in better fitness and fundamental movement skill (FMS), according to a recent pilot trial.